PHS
ALLK

PFM Health Sciences’s Allakos ALLK Stock Holding History

PFM Health Sciences’s Portfolio ALLK Stock Details ALLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-618,284
Closed -$30.2M – 93
2018
Q4 		$30.2M Sell
618,284
-6,451
-1% -$323K 0.8% 50
2018
Q3 		$25.2M Buy
+624,735
New +$25.6M 0.37% 81

Other funds holding ALLK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PFM Health Sciences's ALLK Position: Q1 2019 in Review

PFM Health Sciences sold out of Allakos (ALLK) in Q1 2019, closing a stake of 618,284 shares — an estimated $30.2M sold.

PFM Health Sciences first reported a position in ALLK in Q3 2018 and held it in 2 quarters. The position peaked at $30.2M in Q4 2018. 72 funds tracked by Wall St. Rank hold ALLK as of Q1 2019.

  • PFM Health Sciences reported no remaining Allakos position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 618,284 Allakos shares in Q1 2019, an estimated $30.2M.
  • PFM Health Sciences first reported a position in Allakos in Q3 2018 and held it in 2 quarters.
  • PFM Health Sciences's Allakos position peaked at $30.2M in Q4 2018.
  • 72 funds tracked by Wall St. Rank held Allakos as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.